NCT06360406 - Real-World Treatment Study of Koselugo (Selumetinib) | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

September 30, 2031

Study Completion Date

September 30, 2031

Conditions

Neurofibromatosis 1Neurofibroma, Plexiform

Trial Locations (12)

RECRUITING

Research Site, Busan

RECRUITING

Research Site, Chungcheongbuk-do

RECRUITING

Research Site, Daejeon

RECRUITING

Research Site, Gyeonggi-do

RECRUITING

Research Site, Incheon

RECRUITING

Research Site, Jeonnam

SUSPENDED

Research Site, Seoul

RECRUITING

Research Site, Seoul

COMPLETED

Research Site, Seoul

NOT_YET_RECRUITING

Research Site, Seoul

RECRUITING

Research Site, Wŏnju

RECRUITING

Research Site, Yangsan